Project Grant K99EB037078

Award Date 7/1/25
Completion Date 6/30/27
Dollars Obligated $122K
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
North Carolina, USA
Similar Awards
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $277,033 to support research on novel approaches for introducing radiolabeled trifluoromethyl groups ([11C]CF3 and [18F]CF3) into PET tracers. The award, with a project period from January 1, 2025 to December 31, 2028, aims to develop general strategies for...
This federal Project Grant award of $505,848.59 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) supports research to develop new methods for rapidly producing Positron Emission Tomography (PET) imaging agents labeled with the radioactive isotope fluorine-18. The primary focus is on inventing zinc-mediated and metal-free amide C-H radiofluorination...
This federal Project Grant award R21EB035675, totaling $174,375.00, was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The project aims to develop new methods for incorporating the radioactive isotope fluorine-18 into complex biomolecules using irreversible metal-fluorine bond formation. This is intended to complement and contrast existing...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), is funding the development of a rapid, inexpensive microfluidics-based approach for on-demand production of radiopharmaceuticals. The $1,149,264 award, with a project period from March 1, 2025 to February 28, 2029, aims to reduce barriers associated with...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $275,773 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Dropletpharm Inc., a for-profit company. The grant supports Dropletpharm's development of microfluidic technologies to enable low-cost and distributed manufacturing of radiopharmaceuticals for clinical and research applications. Specifically, the project aims to expand...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), provides $553,775.00 in funding to the University of California, Santa Barbara (UCSB) for research on developing a novel photobiocatalysis strategy to engineer pyridoxal phosphate (PLP)-dependent enzymes as radical enzymes. The goal is to enable...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program, is focused on improving the image quality of Gallium 68-based PET imaging through the development of deep learning-based methods. The $442,037 award aims to create novel motion correction, image reconstruction, and kinetic modeling techniques to enhance the lesion...
This Project Grant award from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) provides $375,665 to the University of California, Davis to install an integrated radiosynthesis system for the production of non-commercially available PET radiotracers for preclinical imaging applications. The system will allow for the automated production of PET radiotracers labeled with fluorine-18, supporting the synthesis of both established and novel radiotracers. This...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) will develop a novel molecular imaging technology that combines positron emission tomography (PET) and ultrasound (US) imaging. The total funding for this award is $1,541,316.00 with a period of performance from September 1, 2024 to May 31, 2028. The key products to be delivered...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $1,114,113 in funding to the University of North Carolina at Chapel Hill (UNC-CH) to develop reactions that enable molecular rigidification. The goal is to create new methods for accessing rigid small and medium-sized strained rings, as well as techniques to stabilize highly reactive alkylidene units using palladium catalysis. The...

This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $122,260 to the University of North Carolina at Chapel Hill to develop new radiofluorination methods and prosthetic groups. The goal is to enable the rapid and iterative construction of PET tracer analogs to support structure-activity relationship (SAR) studies and accelerate the development of radiopharmaceuticals. Specifically, the project will focus on developing late-stage direct radiofluorination methods and new prosthetic groups like radiolabeled isocyanates and strained alkynes for strain-promoted azide-alkyne cycloadditions. These new labeling approaches are intended to facilitate the quick assembly of diverse PET tracer analogs for biodistribution evaluations, advancing SAR research and rapid radiopharmaceutical development. The award period runs from July 1, 2025 to June 30, 2027.

Generated 6/24/25, 5:10 AM